U.K. National Institute of Health Research has launched a really big project (£4 million funded) to test the efficiency of VR in mental health therapy. This project is called “gameChange” and it evolves many partners (both private and public). In particular, it will test VR products of Oxford VR start-up. The first large-scale trial on psychosis patients will bring robust results on VR efficiency next year according to Oxford VR CEO and allows clinicians to…"First Major Trial Of VR Therapy For Serious Mental Health Conditions Launches"
We see more and more pharmaceuticals industries developing digital “add-on” to classical drugs. In this article Otsuka America explain why it’s important to think “beyond medication” to help patient in everyday life. CT-152 is a software application that will use cognitive therapy principles to treat patients either independently or in conjunction with prescribed pharmacotherapies. It is aimed the product will fall under the Food and Drug Administration’s regulatory framework and be classed as Software as…"Digital therapy for depression to be developed through pharma collaboration"